




Searching News Database: Schering
HSMN NewsFeed - 17 Jun 2021
KaliVir Immunotherapeutics Appoints Drs. Terry Hermiston and Jon Wigginton to Board of Directors
KaliVir Immunotherapeutics Appoints Drs. Terry Hermiston and Jon Wigginton to Board of Directors
HSMN NewsFeed - 4 Feb 2019
Sojournix Appoints Ruth Thieroff-Ekerdt, M.D. As Senior Vice President And Chief Medical Officer
Sojournix Appoints Ruth Thieroff-Ekerdt, M.D. As Senior Vice President And Chief Medical Officer
HSMN NewsFeed - 2 Jan 2019
Correvio Announces Chief Executive Officer Succession Plan and Other Board and Executive Changes
Correvio Announces Chief Executive Officer Succession Plan and Other Board and Executive Changes
HSMN NewsFeed - 24 Sep 2018
Tocagen Appoints Mohamed Ladha as Vice President to Establish Commercial Organization
Tocagen Appoints Mohamed Ladha as Vice President to Establish Commercial Organization
HSMN NewsFeed - 13 Apr 2018
Cellenkos, Inc. Announces Alick Sun as Senior Vice President for Corporate and Business Development
Cellenkos, Inc. Announces Alick Sun as Senior Vice President for Corporate and Business Development
HSMN NewsFeed - 6 Jun 2016
Homology Medicines Appoints James Warren, Ph.D. as Vice President of Manufacturing
Homology Medicines Appoints James Warren, Ph.D. as Vice President of Manufacturing
HSMN NewsFeed - 4 Mar 2015
CASI Pharmaceuticals Appoints Rong Chen, MD, Ph.D. As Chief Medical Officer
CASI Pharmaceuticals Appoints Rong Chen, MD, Ph.D. As Chief Medical Officer
HSMN NewsFeed - 10 Jul 2014
Jounce Therapeutics Appoints Richard Murray, Ph.D., to Chief Executive Officer
Jounce Therapeutics Appoints Richard Murray, Ph.D., to Chief Executive Officer
HSMN NewsFeed - 21 May 2014
Provectus Biopharmaceuticals Inc. Appoints Jacob M. Plotsker to Strategic Advisory Board
Provectus Biopharmaceuticals Inc. Appoints Jacob M. Plotsker to Strategic Advisory Board
HSMN NewsFeed - 8 May 2014
Anavex Appoints Senior Healthcare and Pharmaceutical Executives to Board of Directors
Anavex Appoints Senior Healthcare and Pharmaceutical Executives to Board of Directors
HSMN NewsFeed - 13 Mar 2014
Synergy Pharmaceuticals Appoints Marino Garcia as Senior Vice President, Corporate Development
Synergy Pharmaceuticals Appoints Marino Garcia as Senior Vice President, Corporate Development
HSMN NewsFeed - 14 Jan 2014
Actavis Appoints Industry Veterans to Lead U.S. Specialty Brands Business Units
Actavis Appoints Industry Veterans to Lead U.S. Specialty Brands Business Units
HSMN NewsFeed - 15 May 2013
Achillion Appoints Dr. David Apelian as Chief Medical Officer and Expands Clinical Operations Team
Achillion Appoints Dr. David Apelian as Chief Medical Officer and Expands Clinical Operations Team
HSMN NewsFeed - 13 Feb 2013
Lpath Promotes Leigh Hsu, Ph.D., to Vice President of Corporate Development
Lpath Promotes Leigh Hsu, Ph.D., to Vice President of Corporate Development
HSMN NewsFeed - 2 Jul 2012
Antares Pharma Appoints Jonathan S. Jaffe MD Vice President of Clinical Development
Antares Pharma Appoints Jonathan S. Jaffe MD Vice President of Clinical Development
HSMN NewsFeed - 13 Sep 2011
IMMUNE Pharmaceuticals Announces Alan G. Harris MD, PhD, FRCP as Chief Medical Officer
IMMUNE Pharmaceuticals Announces Alan G. Harris MD, PhD, FRCP as Chief Medical Officer
HSMN NewsFeed - 3 Mar 2011
Gentium Appoints Adrian Haigh as Senior Vice President of Commercial Operations
Gentium Appoints Adrian Haigh as Senior Vice President of Commercial Operations
HSMN NewsFeed - 22 Feb 2011
OraSure Technologies Receives FDA Approval for Its OraQuick(R) HCV Rapid Test Using Fingerstick Whole Blood
OraSure Technologies Receives FDA Approval for Its OraQuick(R) HCV Rapid Test Using Fingerstick Whole Blood
HSMN NewsFeed - 19 Jan 2011
Momenta Pharmaceuticals Announces Appointment of Thomas P. Koestler to Board of Directors
Momenta Pharmaceuticals Announces Appointment of Thomas P. Koestler to Board of Directors
HSMN NewsFeed - 18 Jan 2011
ImmunoGen, Inc. Appoints Theresa Wingrove, Ph.D., as Vice President, Regulatory Affairs
ImmunoGen, Inc. Appoints Theresa Wingrove, Ph.D., as Vice President, Regulatory Affairs
HSMN NewsFeed - 29 Nov 2010
MEDRAD(R) Announces Launch of VirtualCARE(R) Remote Services Solution for Intego PET Infusion System
MEDRAD(R) Announces Launch of VirtualCARE(R) Remote Services Solution for Intego PET Infusion System
HSMN NewsFeed - 21 Sep 2010
Jeffrey A. Winton Named Vice President of Communications at Eli Lilly and Company
Jeffrey A. Winton Named Vice President of Communications at Eli Lilly and Company
HSMN NewsFeed - 24 Aug 2010
Regenicin Appoints Amgen Co-founder Dr. Joseph Rubinfeld to Board of Directors
Regenicin Appoints Amgen Co-founder Dr. Joseph Rubinfeld to Board of Directors
HSMN NewsFeed - 20 Aug 2010
Impax Laboratories Confirms Patent Challenge Relating to VYTORIN(R), 10 mg/80 mg
Impax Laboratories Confirms Patent Challenge Relating to VYTORIN(R), 10 mg/80 mg
HSMN NewsFeed - 17 Jun 2010
Bayer and OncoMed Pharmaceuticals Enter Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics
Bayer and OncoMed Pharmaceuticals Enter Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics
HSMN NewsFeed - 16 Jun 2010
GTC Biotherapeutics Announces New $7 Million Financing, Company Restructuring and Management Changes
GTC Biotherapeutics Announces New $7 Million Financing, Company Restructuring and Management Changes
HSMN NewsFeed - 25 Feb 2010
Pharmaceutical Industry Veteran is Appointed CMO at Kinex Pharmaceuticals
Pharmaceutical Industry Veteran is Appointed CMO at Kinex Pharmaceuticals
HSMN NewsFeed - 24 Nov 2009
NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director
NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director
HSMN NewsFeed - 10 Nov 2009
Ismail Kola joins UCB as Executive Vice President, UCB & President of UCB New Medicines(TM)
Ismail Kola joins UCB as Executive Vice President, UCB & President of UCB New Medicines(TM)
HSMN NewsFeed - 27 Oct 2009
AngioDynamics Appoints Stephen McGill as Senior Vice President and General Manager, International
AngioDynamics Appoints Stephen McGill as Senior Vice President and General Manager, International
HSMN NewsFeed - 22 Sep 2009
Micromet Appoints Former Roche Oncology Clinical Leader Jan Fagerberg as Chief Medical Officer
Micromet Appoints Former Roche Oncology Clinical Leader Jan Fagerberg as Chief Medical Officer
HSMN NewsFeed - 11 May 2009
Sanofi-aventis U.S. to Acquire Oral Chronic Lymphocytic Leukemia Treatment
Sanofi-aventis U.S. to Acquire Oral Chronic Lymphocytic Leukemia Treatment
HSMN NewsFeed - 12 Mar 2009
FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)
FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)
HSMN NewsFeed - 23 Feb 2009
Micromet Adds Former Head of Roche Oncology Kapil Dhingra, MD to Board of Directors
Micromet Adds Former Head of Roche Oncology Kapil Dhingra, MD to Board of Directors
HSMN NewsFeed - 5 Jan 2009
Indevus Pharmaceuticals Announces Definitive Merger Agreement With Endo Pharmaceuticals
Indevus Pharmaceuticals Announces Definitive Merger Agreement With Endo Pharmaceuticals
HSMN NewsFeed - 22 Dec 2008
EPIX Pharmaceuticals Announces FDA Approval of Vasovist(R) (gadofosveset trisodium)
EPIX Pharmaceuticals Announces FDA Approval of Vasovist(R) (gadofosveset trisodium)
HSMN NewsFeed - 10 Dec 2008
MorphoSys Appoints Dr. Arndt Schottelius as Chief Development Officer and Member of the Management Board
MorphoSys Appoints Dr. Arndt Schottelius as Chief Development Officer and Member of the Management Board
HSMN NewsFeed - 22 Sep 2008
Medimetriks Pharmaceuticals, Inc. Welcomes Wolfgang Kunze to Its Board of Directors
Medimetriks Pharmaceuticals, Inc. Welcomes Wolfgang Kunze to Its Board of Directors
HSMN NewsFeed - 5 Sep 2008
Questcor Strengthens Management Team's Manufacturing and Commercial Operations Capabilities
Questcor Strengthens Management Team's Manufacturing and Commercial Operations Capabilities
HSMN NewsFeed - 4 Sep 2008
EPIX Pharmaceuticals To Regain Full Worldwide Commercial Rights For Vasovist(R)
EPIX Pharmaceuticals To Regain Full Worldwide Commercial Rights For Vasovist(R)
HSMN NewsFeed - 27 Aug 2008
Confirma and MEDRAD Partner to Advance Patient Care in the European Union
Confirma and MEDRAD Partner to Advance Patient Care in the European Union
HSMN NewsFeed - 19 Aug 2008
Nicholas J. Hart Joins Emisphere as Vice President, Strategy and Development
Nicholas J. Hart Joins Emisphere as Vice President, Strategy and Development
HSMN NewsFeed - 14 Aug 2008
TOPIGEN Pharmaceuticals Appoints Mark Parry-Billings, Ph.D., as Chief Executive Officer
TOPIGEN Pharmaceuticals Appoints Mark Parry-Billings, Ph.D., as Chief Executive Officer
HSMN NewsFeed - 28 Jul 2008
EPIX Pharmaceuticals Announces Resignation of CEO; Names Elkan Gamzu Interim CEO
EPIX Pharmaceuticals Announces Resignation of CEO; Names Elkan Gamzu Interim CEO
HSMN NewsFeed - 17 Jul 2008
NASONEX(R) Now Approved in Japan for the Treatment of Allergic Rhinitis in Adult Patients
NASONEX(R) Now Approved in Japan for the Treatment of Allergic Rhinitis in Adult Patients
HSMN NewsFeed - 8 Jul 2008
Agile Therapeutics Appoints Senior Executive Jeffrey Frick as Chief Business Officer
Agile Therapeutics Appoints Senior Executive Jeffrey Frick as Chief Business Officer
HSMN NewsFeed - 1 Jul 2008
EPIX Pharmaceuticals Announces Resubmission of New Drug Application for Vasovist(R)
EPIX Pharmaceuticals Announces Resubmission of New Drug Application for Vasovist(R)
HSMN NewsFeed - 27 May 2008
ZymoGenetics Announces FDA Approval of RECOTHROM(TM) 20,000-IU Vial Size and Co-Packaging with Spray Kit
ZymoGenetics Announces FDA Approval of RECOTHROM(TM) 20,000-IU Vial Size and Co-Packaging with Spray Kit
HSMN NewsFeed - 9 Apr 2008
Novacea Receives Notification From Schering-Plough of Termination of Collaboration Agreement
Novacea Receives Notification From Schering-Plough of Termination of Collaboration Agreement
HSMN NewsFeed - 17 Mar 2008
Zimmer Holdings, Inc. Adds Robert Hagemann and Cecil Pickett to Board of Directors
Zimmer Holdings, Inc. Adds Robert Hagemann and Cecil Pickett to Board of Directors
HSMN NewsFeed - 4 Mar 2008
Bayer HealthCare and Juvaris BioTherapeutics Announce Major Licensing Agreement
Bayer HealthCare and Juvaris BioTherapeutics Announce Major Licensing Agreement
HSMN NewsFeed - 26 Nov 2007
Pharmasset Appoints Patrick T. Higgins as Executive Vice President, Marketing & Sales
Pharmasset Appoints Patrick T. Higgins as Executive Vice President, Marketing & Sales
HSMN NewsFeed - 26 Sep 2007
Titan Adds Dr. Marc Rubin to Executive Management Team as President and Chief Executive Officer
Titan Adds Dr. Marc Rubin to Executive Management Team as President and Chief Executive Officer
HSMN NewsFeed - 24 Sep 2007
Phase 3 Pivotal Trial of TOCOSOL(R) Paclitaxel Does Not Meet Primary Endpoint
Phase 3 Pivotal Trial of TOCOSOL(R) Paclitaxel Does Not Meet Primary Endpoint
HSMN NewsFeed - 27 Jun 2007
Bayer and Onyx Submit Supplemental New Drug Application for Nexavar to Treat Liver Cancer
Bayer and Onyx Submit Supplemental New Drug Application for Nexavar to Treat Liver Cancer
HSMN NewsFeed - 4 Jun 2007
Avid Radiopharmaceuticals Appoints Ernest Mario, Ph.D. to Board of Directors
Avid Radiopharmaceuticals Appoints Ernest Mario, Ph.D. to Board of Directors
HSMN NewsFeed - 4 Jun 2007
Nexavar Significantly Extends Overall Survival by 44% in Liver Cancer Patients
Nexavar Significantly Extends Overall Survival by 44% in Liver Cancer Patients
HSMN NewsFeed - 3 Jun 2007
Xanthus Announces Phase 1 Results for P2045 - a Targeted Agent for Non-Small Cell Lung Cancer
Xanthus Announces Phase 1 Results for P2045 - a Targeted Agent for Non-Small Cell Lung Cancer
HSMN NewsFeed - 25 Apr 2007
Alkermes and Indevus Announce Initiation of Phase 2a Clinical Study of ALKS 27 for the Treatment of COPD
Alkermes and Indevus Announce Initiation of Phase 2a Clinical Study of ALKS 27 for the Treatment of COPD
HSMN NewsFeed - 10 Apr 2007
TOPIGEN Expands Executive Team With Senior Business Development and Pharmaceutical Development Appointments
TOPIGEN Expands Executive Team With Senior Business Development and Pharmaceutical Development Appointments
HSMN NewsFeed - 19 Mar 2007
Avid Announces Results of AV-1 Molecular Imaging Agent for Alzheimer's Disease Presented at AD/PD Meeting
Avid Announces Results of AV-1 Molecular Imaging Agent for Alzheimer's Disease Presented at AD/PD Meeting
HSMN NewsFeed - 1 Mar 2007
Study Confirms That Significant Insulin Dose Errors Can Result When Blood Glucose Meters are Miscoded
Study Confirms That Significant Insulin Dose Errors Can Result When Blood Glucose Meters are Miscoded
HSMN NewsFeed - 28 Feb 2007
EPIX Pharmaceuticals Files Formal Appeal for Vasovist(TM) with the Center for Drug Evaluation and Research
EPIX Pharmaceuticals Files Formal Appeal for Vasovist(TM) with the Center for Drug Evaluation and Research
HSMN NewsFeed - 5 Feb 2007
Cardium and InnerCool Announce New External and Internal Patient Temperature Modulation Systems
Cardium and InnerCool Announce New External and Internal Patient Temperature Modulation Systems
HSMN NewsFeed - 1 Feb 2007
VioQuest Pharmaceuticals, Inc. Announces Appointment of Chief Scientific Officer
VioQuest Pharmaceuticals, Inc. Announces Appointment of Chief Scientific Officer
HSMN NewsFeed - 19 Jan 2007
Bayer Schering Pharma to Develop New Imaging Compounds for Detection of Neurodegenerative Diseases
Bayer Schering Pharma to Develop New Imaging Compounds for Detection of Neurodegenerative Diseases
HSMN NewsFeed - 18 Dec 2006
Neuro Diagnostic Devices (NeuroDx) Names Industry Veteran Frederick Fritz as CEO and President
Neuro Diagnostic Devices (NeuroDx) Names Industry Veteran Frederick Fritz as CEO and President
HSMN NewsFeed - 14 Dec 2006
EPIX Pharmaceuticals to File Appeal with the Center for Drug Evaluation and Research for Vasovist(TM)
EPIX Pharmaceuticals to File Appeal with the Center for Drug Evaluation and Research for Vasovist(TM)
HSMN NewsFeed - 23 Nov 2006
Betaferon(R) Approved in Australia for Earliest Stages of Multiple Sclerosis
Betaferon(R) Approved in Australia for Earliest Stages of Multiple Sclerosis
HSMN NewsFeed - 20 Nov 2006
Actelion Announces Definitive Agreement to Acquire U.S.-Based CoTherix, Inc.
Actelion Announces Definitive Agreement to Acquire U.S.-Based CoTherix, Inc.
HSMN NewsFeed - 15 Nov 2006
Chiasma Raises $44 Million Series C to Fund Clinical Testing, Advance Technology
Chiasma Raises $44 Million Series C to Fund Clinical Testing, Advance Technology
HSMN NewsFeed - 13 Nov 2006
Treatment of Diabetic Foot Ulcers to Be Addressed at Upcoming American Heart Association Meeting
Treatment of Diabetic Foot Ulcers to Be Addressed at Upcoming American Heart Association Meeting
HSMN NewsFeed - 9 Nov 2006
Bayer Outlines New Global R&D Structures; U.S. Pharma Sites and Future Headquarters
Bayer Outlines New Global R&D Structures; U.S. Pharma Sites and Future Headquarters
HSMN NewsFeed - 31 Oct 2006
Berlex Oncology Evaluating Combination Therapy for Common Form of Non-Hodgkin's Lymphoma
Berlex Oncology Evaluating Combination Therapy for Common Form of Non-Hodgkin's Lymphoma
HSMN NewsFeed - 23 Oct 2006
FDA Approves Betaseron(R) for Use After the First Event Suggestive of Multiple Sclerosis
FDA Approves Betaseron(R) for Use After the First Event Suggestive of Multiple Sclerosis
HSMN NewsFeed - 20 Oct 2006
Indevus Announces the Finalization of Supply Agreement with Schering AG, Germany for NEBIDO(R)
Indevus Announces the Finalization of Supply Agreement with Schering AG, Germany for NEBIDO(R)
HSMN NewsFeed - 17 Oct 2006
Inovio Biomedical Acquires Rights to DNA Vaccine Licenses and Intellectual Property from Valentis
Inovio Biomedical Acquires Rights to DNA Vaccine Licenses and Intellectual Property from Valentis
HSMN NewsFeed - 12 Oct 2006
KaloBios Pharmaceuticals Appoints David W. Pritchard as President and Chief Executive Officer
KaloBios Pharmaceuticals Appoints David W. Pritchard as President and Chief Executive Officer
HSMN NewsFeed - 10 Oct 2006
GeoPharma Announces Schering-Plough Lawsuit Related to Generic Version of Clarinex(R)
GeoPharma Announces Schering-Plough Lawsuit Related to Generic Version of Clarinex(R)
HSMN NewsFeed - 6 Oct 2006
SUBOXONE(R) (Buprenorphine/Naloxone) Approved In European Union for Treatment of Opioid Dependence
SUBOXONE(R) (Buprenorphine/Naloxone) Approved In European Union for Treatment of Opioid Dependence
HSMN NewsFeed - 18 Sep 2006
Bausch & Lomb Licenses SEGRA Compound From Schering AG for Ophthalmic Use
Bausch & Lomb Licenses SEGRA Compound From Schering AG for Ophthalmic Use
HSMN NewsFeed - 15 Sep 2006
Schering AG and AstraZeneca Form Strategic Alliance to Develop Novel Anti-Cancer Drug
Schering AG and AstraZeneca Form Strategic Alliance to Develop Novel Anti-Cancer Drug
HSMN NewsFeed - 6 Sep 2006
Xanthus Pharmaceuticals Licenses Novel Cancer Targeting Agents From Schering AG, Berlin
Xanthus Pharmaceuticals Licenses Novel Cancer Targeting Agents From Schering AG, Berlin
HSMN NewsFeed - 28 Aug 2006
EPIX Pharmaceuticals Receives Response from the FDA Regarding Appeal of Vasovist(TM) Approvable Letters
EPIX Pharmaceuticals Receives Response from the FDA Regarding Appeal of Vasovist(TM) Approvable Letters
HSMN NewsFeed - 2 Aug 2006
New MEDRAD 3.0T Prostate eCoil(TM) Enables Personalized Treatment Planning
New MEDRAD 3.0T Prostate eCoil(TM) Enables Personalized Treatment Planning
HSMN NewsFeed - 27 Jul 2006
Premier Inc. Announces Imaging Group Buy With Philips Medical, Mallinckrodt, and Medrad
Premier Inc. Announces Imaging Group Buy With Philips Medical, Mallinckrodt, and Medrad
HSMN NewsFeed - 20 Jul 2006
Berlex Issues Nationwide Recall of a Single Lot of Ultravist(R) Injection 370 mgI/mL, 125 mL in the U.S.
Berlex Issues Nationwide Recall of a Single Lot of Ultravist(R) Injection 370 mgI/mL, 125 mL in the U.S.
HSMN NewsFeed - 30 Jun 2006
EPIX Pharmaceuticals Files Appeal with FDA Regarding Vasovist(TM) Approvable Letters
EPIX Pharmaceuticals Files Appeal with FDA Regarding Vasovist(TM) Approvable Letters
HSMN NewsFeed - 26 Jun 2006
NexMed Announces Termination of Alprox-TD Agreement With Schering AG and Provides Operational Update
NexMed Announces Termination of Alprox-TD Agreement With Schering AG and Provides Operational Update
HSMN NewsFeed - 21 Jun 2006
Celera Genomics Announces the Sale of Its Cathepsin S Inhibitor Program to Schering AG
Celera Genomics Announces the Sale of Its Cathepsin S Inhibitor Program to Schering AG
HSMN NewsFeed - 20 Jun 2006
Cellegy Pharmaceuticals Appoints Agis to Distribute Rectogesic(R) in Israel
Cellegy Pharmaceuticals Appoints Agis to Distribute Rectogesic(R) in Israel
HSMN NewsFeed - 7 Jun 2006
Betaferon(R) Approved in Europe as a First-Line Treatment for the Earliest Stages of Multiple Sclerosis
Betaferon(R) Approved in Europe as a First-Line Treatment for the Earliest Stages of Multiple Sclerosis
HSMN NewsFeed - 1 Jun 2006
Dr. Gabor Rubanyi of Berlex Biosciences Joins Cardium as Chief Scientific Officer
Dr. Gabor Rubanyi of Berlex Biosciences Joins Cardium as Chief Scientific Officer
HSMN NewsFeed - 26 May 2006
MultiCell Technologies Appoints Stephen Chang, Ph.D. as Chief Executive Officer
MultiCell Technologies Appoints Stephen Chang, Ph.D. as Chief Executive Officer
HSMN NewsFeed - 22 May 2006
Xanthus Pharmaceuticals Appoints John Lister-James, Ph.D. as Vice President, Development
Xanthus Pharmaceuticals Appoints John Lister-James, Ph.D. as Vice President, Development
HSMN NewsFeed - 16 May 2006
Genitope Corporation Appoints Dr. Mary Rybak Vice President of Medical Affairs
Genitope Corporation Appoints Dr. Mary Rybak Vice President of Medical Affairs
HSMN NewsFeed - 10 May 2006
Axcan Pharma appoints new Senior Vice President and Chief Scientific Officer
Axcan Pharma appoints new Senior Vice President and Chief Scientific Officer
HSMN NewsFeed - 18 Apr 2006
Executive Board and Supervisory Board Recommend Acceptance of Bayer Offer for Takeover of Schering AG
Executive Board and Supervisory Board Recommend Acceptance of Bayer Offer for Takeover of Schering AG
HSMN NewsFeed - 17 Mar 2006
FDA Approves YAZ(R), the First Oral Contraceptive to Offer Drospirenone in a 24-Day, Active-Pill Regimen
FDA Approves YAZ(R), the First Oral Contraceptive to Offer Drospirenone in a 24-Day, Active-Pill Regimen
HSMN NewsFeed - 17 Mar 2006
Schering AG Receives FDA Approval for New Low Dose Oral Contraceptive YAZ(R) with 24-day Regimen
Schering AG Receives FDA Approval for New Low Dose Oral Contraceptive YAZ(R) with 24-day Regimen
HSMN NewsFeed - 14 Mar 2006
Cardium Announces Addition of Kelly D. Scott as Vice President of New Medical Technology Business
Cardium Announces Addition of Kelly D. Scott as Vice President of New Medical Technology Business
HSMN NewsFeed - 9 Mar 2006
Cardium Acquires InnerCool Therapies, a Leading Provider of FDA-Cleared Therapeutic Hypothermia Systems
Cardium Acquires InnerCool Therapies, a Leading Provider of FDA-Cleared Therapeutic Hypothermia Systems
HSMN NewsFeed - 26 Jan 2006
Taro Receives Tentative Approval for Augmented Betamethasone Dipropionate Lotion ANDA
Taro Receives Tentative Approval for Augmented Betamethasone Dipropionate Lotion ANDA
HSMN NewsFeed - 25 Jan 2006
Carlo Montagner to Be Named President of Abraxis Oncology Upon Completion of Merger of APP and ABI
Carlo Montagner to Be Named President of Abraxis Oncology Upon Completion of Merger of APP and ABI
HSMN NewsFeed - 23 Jan 2006
Cardium Therapeutics Announces Appointment of Chief Medical Officer to Lead Generx(TM) Development Program
Cardium Therapeutics Announces Appointment of Chief Medical Officer to Lead Generx(TM) Development Program
HSMN NewsFeed - 10 Jan 2006
Berlex Oncology Introduces New Formulation of Leukine(R) With Extended Shelf Life
Berlex Oncology Introduces New Formulation of Leukine(R) With Extended Shelf Life
HSMN NewsFeed - 4 Jan 2006
FDA Approves Osteoporosis Indication for Once-a-Week Hormone Therapy Patch, Climara Pro(R)
FDA Approves Osteoporosis Indication for Once-a-Week Hormone Therapy Patch, Climara Pro(R)
Additional items found! 288

Members Archive contains
288 additional stories matching:
Schering
(Password required)
Schering
(Password required)